- Report
- January 2024
- 80 Pages
Saudi Arabia
From €1481EUR$1,500USD£1,233GBP
- Report
- January 2024
- 80 Pages
South Korea
From €1481EUR$1,500USD£1,233GBP
- Report
- January 2024
- 80 Pages
Vietnam
From €1481EUR$1,500USD£1,233GBP
- Report
- December 2023
- 80 Pages
India
From €1481EUR$1,500USD£1,233GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €1481EUR$1,500USD£1,233GBP
- Report
- December 2023
- 80 Pages
United Kingdom
From €1481EUR$1,500USD£1,233GBP
From €1481EUR$1,500USD£1,233GBP
- Report
- December 2023
- 80 Pages
South Korea
From €1481EUR$1,500USD£1,233GBP
- Report
- December 2023
- 80 Pages
Poland
From €1481EUR$1,500USD£1,233GBP
- Report
- December 2023
- 80 Pages
Argentina
From €1481EUR$1,500USD£1,233GBP
- Report
- October 2023
- 180 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- October 2023
- 80 Pages
Saudi Arabia
From €1481EUR$1,500USD£1,233GBP
- Report
- October 2023
- 80 Pages
India
From €1481EUR$1,500USD£1,233GBP
- Report
- October 2023
- 80 Pages
Germany
From €1481EUR$1,500USD£1,233GBP
- Report
- October 2023
- 80 Pages
France
From €1481EUR$1,500USD£1,233GBP
- Report
- October 2023
- 80 Pages
United States
From €1481EUR$1,500USD£1,233GBP
- Report
- October 2023
- 80 Pages
United Kingdom
From €1481EUR$1,500USD£1,233GBP
From €1481EUR$1,500USD£1,233GBP
- Report
- October 2023
- 80 Pages
South Korea
From €1481EUR$1,500USD£1,233GBP
- Report
- April 2023
- 80 Pages
United States
From €1481EUR$1,500USD£1,233GBP
The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more